197 related articles for article (PubMed ID: 31191875)
1. The nuclear export inhibitor aminoratjadone is a potent effector in extracellular-targeted drug conjugates.
Klahn P; Fetz V; Ritter A; Collisi W; Hinkelmann B; Arnold T; Tegge W; Rox K; Hüttel S; Mohr KI; Wink J; Stadler M; Wissing J; Jänsch L; Brönstrup M
Chem Sci; 2019 May; 10(20):5197-5210. PubMed ID: 31191875
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Aminoratjadone Derivatives as Potent Noncovalent CRM1 Inhibitors.
Jian L; Zscherp R; Beutling U; Shen X; Xu S; Zhang X; Brönstrup M; Klahn P; Sun Q
J Med Chem; 2023 Sep; 66(17):11940-11950. PubMed ID: 37595020
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
4. Ratjadones inhibit nuclear export by blocking CRM1/exportin 1.
Köster M; Lykke-Andersen S; Elnakady YA; Gerth K; Washausen P; Höfle G; Sasse F; Kjems J; Hauser H
Exp Cell Res; 2003 Jun; 286(2):321-31. PubMed ID: 12749860
[TBL] [Abstract][Full Text] [Related]
5. Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation.
Kelly PM; Keely NO; Bright SA; Yassin B; Ana G; Fayne D; Zisterer DM; Meegan MJ
Molecules; 2017 Aug; 22(9):. PubMed ID: 28858267
[TBL] [Abstract][Full Text] [Related]
6. The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway.
Fleta-Soriano E; Martinez JP; Hinkelmann B; Gerth K; Washausen P; Diez J; Frank R; Sasse F; Meyerhans A
Microb Cell Fact; 2014 Jan; 13():17. PubMed ID: 24475978
[TBL] [Abstract][Full Text] [Related]
7. Small molecule targeted NIR dye conjugate for imaging LHRH receptor positive cancers.
Roy J; Kaake M; Low PS
Oncotarget; 2019 Jan; 10(2):152-160. PubMed ID: 30719210
[TBL] [Abstract][Full Text] [Related]
8. Bifunctional gonadotropin-releasing hormone antagonist-progesterone analogs with increased efficacy and duration of action.
Ratcliffe KE; Fraser HM; Sellar R; Rivier J; Millar RP
Endocrinology; 2006 Jan; 147(1):571-9. PubMed ID: 16223868
[TBL] [Abstract][Full Text] [Related]
9. Improved Total Synthesis of Tubulysins and Design, Synthesis, and Biological Evaluation of New Tubulysins with Highly Potent Cytotoxicities against Cancer Cells as Potential Payloads for Antibody-Drug Conjugates.
Nicolaou KC; Erande RD; Yin J; Vourloumis D; Aujay M; Sandoval J; Munneke S; Gavrilyuk J
J Am Chem Soc; 2018 Mar; 140(10):3690-3711. PubMed ID: 29381062
[TBL] [Abstract][Full Text] [Related]
10. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.
Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J
Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935
[TBL] [Abstract][Full Text] [Related]
11. Novel Crizotinib-GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems.
Murányi J; Varga A; Gyulavári P; Pénzes K; Németh CE; Csala M; Pethő L; Csámpai A; Halmos G; Peták I; Vályi-Nagy I
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717403
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
[TBL] [Abstract][Full Text] [Related]
13. High-content screening of natural products reveals novel nuclear export inhibitors.
Cautain B; de Pedro N; Murillo Garzón V; Muñoz de Escalona M; González Menéndez V; Tormo JR; Martin J; El Aouad N; Reyes F; Asensio F; Genilloud O; Vicente F; Link W
J Biomol Screen; 2014 Jan; 19(1):57-65. PubMed ID: 24045581
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro stability, and antiproliferative effect of d-cysteine modified GnRH-doxorubicin conjugates.
Li S; Zhao H; Chang X; Wang J; Zhao E; Yin Z; Mao X; Deng S; Hao T; Wang H; Yang Y
J Pept Sci; 2019 Jan; 25(1):e3135. PubMed ID: 30467919
[TBL] [Abstract][Full Text] [Related]
15. Targeting cytotoxic conjugates of somatostatin, luteinizing hormone-releasing hormone and bombesin to cancers expressing their receptors: a "smarter" chemotherapy.
Nagy A; Schally AV
Curr Pharm Des; 2005; 11(9):1167-80. PubMed ID: 15853664
[TBL] [Abstract][Full Text] [Related]
16. Multiplexed cellular profiling identifies an organoselenium compound as an inhibitor of CRM1-mediated nuclear export.
Jimenez L; Mayoral-Varo V; Amenábar C; Ortega J; Sequeira JGN; Machuqueiro M; Mourato C; Silvestri R; Angeli A; Carta F; Supuran CT; Megías D; Ferreira BI; Link W
Traffic; 2022 Dec; 23(12):587-599. PubMed ID: 36353954
[TBL] [Abstract][Full Text] [Related]
17. Total Synthesis and Biological Evaluation of Natural and Designed Tubulysins.
Nicolaou KC; Yin J; Mandal D; Erande RD; Klahn P; Jin M; Aujay M; Sandoval J; Gavrilyuk J; Vourloumis D
J Am Chem Soc; 2016 Feb; 138(5):1698-708. PubMed ID: 26829208
[TBL] [Abstract][Full Text] [Related]
18. Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide.
Taheri A; Dinarvand R; Atyabi F; Ahadi F; Nouri FS; Ghahremani MH; Ostad SN; Borougeni AT; Mansoori P
Int J Mol Sci; 2011; 12(7):4591-608. PubMed ID: 21845098
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1.
Bogerd HP; Echarri A; Ross TM; Cullen BR
J Virol; 1998 Nov; 72(11):8627-35. PubMed ID: 9765402
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
